Categories

North America Defibrillators Market (2016-2022)

US$ 1500

“The North America Defibrillators Market Has A Potential To Reach $ 5,748.9 Million By 2022. Innovation Of Advanced Defibrillator Devices, Growing Population With Elevated Risk Of Targeted Diseases, And Increasing Incidence Of Cardiac Diseases That Are Prevalent In All Age Groups Have Been Responsible For The Market Growth.

11-09 2016   Pages: 94

Global Defibrillators Market (2016-2022)

US$ 3600

“The Global defibrillators market has a potential to reach $ 17,798.5 million by 2022. Defibrillators are devices that are basically used to deliver a therapeutic shock to patients’ heart in case of life-threatening medical conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia.

11-09 2016   Pages: 316

LAMEA Coronary Stents Market (2016-2022)

US$ 1500

“The LAMEA coronary stent market was estimated to attain a market size of $1.3 billion in 2015 and is expected to grow at a CAGR of 7.9 % during the forecast period (2016 – 2022).
The Brazil region would continue its dominance and would attain a market size of $1.3 billion by 2022. The Drug Eluting Stents segment is expected to further grow at a CAGR of 7.1% during the forecast period thereby maintaining its dominance in the LAMEA market. However, the Bioresorable Vascular Scaffold segment would grow at the highest CAGR.

11-09 2016   Pages: 120

Asia Pacific Coronary Stents Market (2016-2022)

US$ 1500

“The Asia Pacific coronary stent market is expected to attain a market size of $3.5 billion by 2022 growing at a CAGR of 9.5 % during the forecast period (2016 – 2022).
The China region would continue its dominance and would attain a market size of $1.7 billion by 2022. The Drug Eluting Stents segment is expected to further grow at a CAGR of 8.6% during the forecast period thereby maintaining its dominance in the Asia Pacific market. However, the Bioresorable Vascular Scaffold segment would grow at the highest CAGR.

11-09 2016   Pages: 101

Europe Coronary Stents Market (2016-2022)

US$ 1500

“The Europe coronary stent market is expected to attain a market size of $3.3 billion by 2022 growing at a CAGR of 5.6 % during the forecast period (2016 – 2022).

11-09 2016   Pages: 97

North America Coronary Stents Market (2016-2022)

US$ 1500

“The North America coronary stent market was estimated to attain a market size of $3 billion in 2015 and is expected to grow at a CAGR of 5.4 % during the forecast period (2016 – 2022).

11-09 2016   Pages: 84

Global Coronary Stents Market (2016-2022)

US$ 3600

“The Coronary stents market during the year 2015 was valued at USD 8,532.0 million, and the market is expected to rise and witness a CAGR of 6.9% during the forecast period. The demand for coronary stents can be attributed to growing incidences of cardiovascular disorders among the human population worldwide. Unhealthy lifestyle among working class has had a huge impact on the health. Due to unhealthy lifestyle among masses, the incidences of cardiovascular conditions have significantly increased over the years. Some of the leading causes of the condition are smoking, physical inactivity, and dietary changes among the masses. These lifestyle changes have led to greater possibility of hypertension, obesity, and blocks in arteries.

11-09 2016   Pages: 346

LAMEA COPD & Asthma Devices Market (2016-2022)

US$ 1500

“The LAMEA COPD & Asthma Device Market is expected to reach $ 6,951.1 Million by 2022 growing at a CAGR of 6.1% CAGR during 2016 – 2022.

11-09 2016   Pages: 134

Asia Pacific COPD & Asthma Devices Market (2016-2022)

US$ 1500

“Asia Pacific is expected to be the fastest regional market for asthma and COPD devices owing to the increased incidence of asthma & other respiratory diseases in industrial regions. The Asia Pacific market for Asthma & COPD has been analyzed on the basis of drugs and devices used for these diseases.

11-09 2016   Pages: 134

Europe COPD & Asthma Devices Market (2016-2022)

US$ 1500

“Growing aging population coupled with increasing automotive and industrial exhaust gases have remained the key drivers for the Europe asthma and COPD market. Degrading air quality near the industrial areas has led to the increased incidence of asthma. Increasing disposable income levels in emerging economies as well as developing countries has led to the increased usage of asthma pumps and sprays in these regions.

11-09 2016   Pages: 134
Contact With Us
Join templatemonster at google+
Customized Research
Request Sample